Citations

Showing 10 of 108094 citations.

Extensive intraluminal thrombus involving the extracranial internal carotid artery
Weil, Erika L. , Klaas, James P.

Mayo Clinic

Practical Neurology | June 10, 2022 | Volume: 22 | Issue: 4 | Pages: 332-333

10.1136/practneurol-2022-003391 | PMID 35688620 Get It

Risk of Postoperative Thromboembolism in Men Undergoing Urological Prosthetic Surgery: An Assessment of 21,413 Men
Hebert, Kevin , Matta, Rano , Horns, Joshua J. , Paudel, Niraj, Das, Rupam , Köhler, Tobias , McCormick, Benjamin J. , Hotaling, James M. , Myers, Jeremy B. , Hebert, Kevin J , McCormick, Benjamin J , Myers, Jeremy B , Pastuszak, Alexander W.

Mayo Clinic

Journal of Urology | June 10, 2022 | Volume: 208 | Issue: 4 | Pages: 878-885

10.1097/ju.0000000000002801 | PMID 35686836 Get It

The Impact of a Group Telemedicine Program for Chronic Disease: A Retrospective Cohort Survey Study on Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder
Knight, Dacre , Bruno, Katelyn A. , Gehin, Jessica M. , Lothman, Kristin A., Leschitz, John, Lazo, Amanda L., Mejia, Lisa, Motherwell, Lesley S., Seymour-Sonnier, Andrea M., Dawson, Nancy L. , Fairweather, DeLisa , Knight, Dacre R T , Fairweather, DeLisa , Bruno, Katelyn A

Mayo Clinic

Telemedicine and e-Health | June 10, 2022 | Volume: 29 | Issue: 2 | Pages: 261-269

10.1089/tmj.2022.0092 | PMID 35687402 Get It

Background: We present an innovative care model for telehealth by creating a video conference group telemedicine program for patients with chronic disease and discuss findings from a post-program survey that was instrumental in understanding the response to telemedicine in a group setting. Methods: All patients who attended the group telemedicine program had a diagnosis of Hypermobile Ehlers-Danlos Syndrome or Hypermobility Spectrum Disorder and were requested to complete survey responses at the close of the program. Surveys were completed anonymously and electronically by REDCap. Elements of the Press Ganey, Consumer Assessment of Healthcare Providers and Systems, and Utah Telehealth Network patient satisfaction surveys were modified to construct the survey. Results: A total of 102 patients completed the post-telehealth program survey between August 20, 2021, and February 11, 2022. Around 93.1% stated that they gained a better understanding of the chronic condition, 88.3% stated that the program gave them the tools to improve, and 76.5% indicated the program addressed their specific needs. Approximately 92.1% found it easy to interact with the program facilitator and 79.4% found it easy to interact with program members. Around 93.1% said they would recommend the program to others. Discussion: We created a group telemedicine program for a complex chronic medical condition. The foundation of knowledge provided by the telemedicine program allowed more time during face-to-face encounters for individual assessment of the patient, and increased access to care. Overall, the program has improved the treatment process by reducing treatment burden and empowering patients with self-management skills to help reach our fundamental treatment goal of improving quality of life.
Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019
Desai, Aakash , Krell, Jonathan , Desai, Aakash P , Lythgoe, Mark Peter , Gyawali, Bishal , Savage, Philip M. , Warner, Jeremy L. , Khaki, Ali Raza

Mayo Clinic

JAMA Network Open | June 10, 2022 | Volume: 5 | Issue: 6 | Pages: e2216183

10.1001/jamanetworkopen.2022.16183 | PMID 35687337 Get It

Diabetes Mellitus and Subsite-Specific Colorectal Cancer Risks in the Iowa Women's Health Study
Anderson, Kristin E. , Johnson, Trista, Jacobs, David R. , Lazovich, DeAnn, Hong, Ching-Ping, Nicodemus, Kristin K., Folsom, Aaron R. , Jacobs, David R , Limburg, Paul J.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 10, 2022 | Volume: 14 | Issue: 1 | Pages: 133-137

10.1158/1055-9965.133.14.1 Get It

Abstract Objective: Controversy remains regarding the association between type 2 diabetes mellitus (DM) and colorectal cancer (CRC) risk. To clarify and extend the existing data, we prospectively evaluated the association between self-reported type 2 DM (onset at >30 years of age) and incident CRC, overall and by anatomic subsite, among postmenopausal women in the Iowa Women's Health Study (n = 35,230). Methods: After 14 years of follow-up, a total of 870 incident CRC cases were identified through annual linkage to the Iowa Cancer Registry. DM was analyzed as reported at baseline and as a time-dependent variable using information obtained during follow-up. CRC risks were estimated using Cox proportional hazards regression models. Results: After adjusting for age, body mass index and other potential confounding variables, the relative risk (RR) for women with DM versus women without DM was modestly increased at 1.4 [95% confidence interval (95% CI), 1.1-1.8]. By anatomic subsite, the RR for proximal colon cancer was statistically significantly increased (RR, 1.9; 95% CI, 1.3-2.6), whereas the RRs for distal colon (RR, 1.1; 95% CI, 0.6-1.8) and rectal cancer (RR, 0.8; 95% CI, 0.4-1.6) were not statistically different from unity. Analyses that included DM ascertained at baseline and follow-up yielded similar results. Conclusion: In this large, prospective study of postmenopausal women, the association between DM and incident CRC was found to be subsite specific. If confirmed by others, this finding implies that CRC prevention strategies among type 2 DM patients should include examination of the proximal colon.
Insulin-Like Growth Factor (IGF)-1, IGF-Binding Protein-3, and Pancreatic Cancer in Male Smokers
Virtamo, Jarmo, Stolzenberg‐Solomon, Rachael Z. , Limburg, Paul J. , Pollak, Michaël , Taylor, Philip R. , Albanes, Demetrius

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 10, 2022 | Volume: 13 | Issue: 3 | Pages: 438-444

10.1158/1055-9965.438.13.3 Get It

Abstract To investigate whether insulin-like growth factor (IGF)-1 and IGF-binding protein-3 (IGFBP-3) are prospectively associated with exocrine pancreatic cancer, we conducted a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort of 29,133 male Finnish smokers, aged 50–69 years. To avoid the potential influence of subclinical cancer on IGF-1 and IGFBP-3, all subjects in this study were alive without clinical evidence of cancer during their 5th year of the cohort follow-up. Four hundred randomly selected cohort controls and 93 incident pancreatic adenocarcinoma cases that occurred between their 5th follow-up year through 1997 (i.e., up to 12.7 years of follow-up) were included in this study. Concentrations of IGF-1 and IGFBP-3 were measured in serum samples obtained at baseline using ELISA. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression models, adjusted for confounders. Neither IGF-1, IGFBP-3, nor the IGF-1:IGFBP-3 molar ratio was significantly associated with pancreatic cancer: highest compared to lowest tertile, OR = 0.67, 95% CI 0.37–1.21, P trend = 0.17; OR = 0.70, 95% CI 0.38–1.27, P trend = 0.12; and OR = 0.85, 95% CI 0.50–1.46, P trend = 0.54, respectively. Our results do not support the hypothesis that serum IGF-1 and IGFBP-3 concentrations are associated with pancreatic cancer risk among male smokers. Further studies are necessary to evaluate these associations in other populations.
Delirium prediction in the ICU: designing a screening tool for preventive interventions
Sheikhalishahi, Seyedmostafa , Torbic, Heather , Yeung, Wesley , Wang, Tiffany , Birst, Jennifer, Osmani, Venet , Bhattacharyya, Anirban , Osmani, Venet , Duggal, Abhijit , Celi, Leo Anthony

Mayo Clinic

JAMIA Open | June 10, 2022 | Volume: 5 | Issue: 2 | Pages: No page available

10.1093/jamiaopen/ooac048 | PMID 35702626 Get It

Abstract Introduction Delirium occurrence is common and preventive strategies are resource intensive. Screening tools can prioritize patients at risk. Using machine learning, we can capture time and treatment effects that pose a challenge to delirium prediction. We aim to develop a delirium prediction model that can be used as a screening tool. Methods From the eICU Collaborative Research Database (eICU-CRD) and the Medical Information Mart for Intensive Care version III (MIMIC-III) database, patients with one or more Confusion Assessment Method-Intensive Care Unit (CAM-ICU) values and intensive care unit (ICU) length of stay greater than 24 h were included in our study. We validated our model using 21 quantitative clinical parameters and assessed performance across a range of observation and prediction windows, using different thresholds and applied interpretation techniques. We evaluate our models based on stratified repeated cross-validation using 3 algorithms, namely Logistic Regression, Random Forest, and Bidirectional Long Short-Term Memory (BiLSTM). BiLSTM represents an evolution from recurrent neural network-based Long Short-Term Memory, and with a backward input, preserves information from both past and future. Model performance is measured using Area Under Receiver Operating Characteristic, Area Under Precision Recall Curve, Recall, Precision (Positive Predictive Value), and Negative Predictive Value metrics. Results We evaluated our results on 16 546 patients (47% female) and 6294 patients (44% female) from eICU-CRD and MIMIC-III databases, respectively. Performance was best in BiLSTM models where, precision and recall changed from 37.52% (95% confidence interval [CI], 36.00%–39.05%) to 17.45 (95% CI, 15.83%–19.08%) and 86.1% (95% CI, 82.49%–89.71%) to 75.58% (95% CI, 68.33%–82.83%), respectively as prediction window increased from 12 to 96 h. After optimizing for higher recall, precision and recall changed from 26.96% (95% CI, 24.99%–28.94%) to 11.34% (95% CI, 10.71%–11.98%) and 93.73% (95% CI, 93.1%–94.37%) to 92.57% (95% CI, 88.19%–96.95%), respectively. Comparable results were obtained in the MIMIC-III cohort. Conclusions Our model performed comparably to contemporary models using fewer variables. Using techniques like sliding windows, modification of threshold to augment recall and feature ranking for interpretability, we addressed shortcomings of current models.
Association of hospital and community factors on the attainment of Baby‐Friendly designation: A breastfeeding health promotion
Tafili, Aurora , Zakari, Nazik , Hamadi, Hanadi , Spaulding, Aaron , Zakari, Nazik M A , Hamadi, Hanadi Y , Spaulding, Aaron

Mayo Clinic

Maternal & Child Nutrition | June 10, 2022 | Volume: 18 | Issue: 3 | Pages: No page available

10.1111/mcn.13388 | PMID 35686458 Get It

AbstractThe Baby‐Friendly Hospital Initiative is a global health promotion intervention that outlines the Ten Steps hospitals should implement to support newborns' breastfeeding. This US‐based study aimed to determine which hospital characteristics and community factors are associated with hospitals' attainment of Baby‐Friendly designation. We used a cross‐sectional design and used 2018 data from the Baby‐Friendly, USA Inc. designation program merged with the American Hospital Association annual survey data set. Multilevel logistic regression analysis was used to assess hospital characteristics of interest among the sample consisting of 312 Baby‐Friendly hospitals and 1449 non‐Baby‐Friendly. Our results show that Baby‐Friendly hospitals are more likely to be government nonfederal hospitals, in the Midwest or South regions, serve communities with higher birth totals, and reside in competitive markets. Based on the results of this study, hospitals should seek further and examine their community's characteristics and structures to identify opportunities and encourage the attainment of improved breastfeeding initiatives such as Baby‐Friendly designation.
Risk of Non-Hodgkin's Lymphoma and Family History of Lymphatic, Hematologic, and Other Cancers
Chatterjee, Nilanjan , Hartge, Patricia, Ishibe, Naoko, Colt, Joanne S., Goldin, Lynn R. , Severson, Richard K., Cerhan, James R. , Cozen, Wendy , Davis, Scott

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 10, 2022 | Volume: 13 | Issue: 9 | Pages: 1415-1421

10.1158/1055-9965.1415.13.9 Get It

Abstract Background: An elevated risk of developing non-Hodgkin's lymphoma (NHL) has been associated with a family history of NHL and several other malignancies, but the magnitude of risks and mechanisms are uncertain. Methods: We used self-reported family history data from a recent multicenter U.S.-based case-control studies of NHL to evaluate familial aggregation of NHL with various hematolymphoproliferative and other cancers. Estimates of familial aggregation were obtained as hazard ratios (HR) that compare incidence of different cancers in first-degree relatives of NHL cases with that in the first-degree relatives of NHL controls. Limitations of the study included low participation rates (76% for cases and 52% for controls) and potential differential accuracy of recall. Results: Risk of NHL was elevated in relatives of NHL cases [HR, 2.9; 95% confidence interval (95% CI), 0.95–8.53]; the aggregation seems to be stronger for siblings (HR, 7.6; 95% CI, 0.98–58.8) and for male relatives (HR, 6.2; 95% CI, 0.77–50.0). Risk of Hodgkin's lymphoma seems to be also elevated among relatives of early-onset (<50 years) NHL cases (HR, 3.2; 95% CI, 0.88–11.6). Evaluation of family history of other cancers provided modest evidence for an increased risk of melanoma of the skin (HR, 2.9; 95% CI, 1.08–7.75), pancreatic cancer (HR, 2.1; 95% CI, 0.96–4.43), stomach cancer (HR, 1.8; 95% CI, 0.91–3.63), and prostate cancer (HR, 1.3; 95% CI, 0.87–1.99). Conclusions: These results are consistent with previous findings of familial aggregation of NHL, Hodgkin's lymphoma, and a few other cancers. The pattern of male-specific and sibling-specific familial aggregation of NHL we observed, if confirmed, may shed new light on the possible mechanisms that underlie familial aggregation of the disease.
Body Mass Index and Risk of Leukemia in Older Women
Ross, Julie A. , Folsom, Aaron R. , Parker, Emily D. , Blair, Cindy K. , Cerhan, James R.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 10, 2022 | Volume: 13 | Issue: 11 | Pages: 1810-1813

10.1158/1055-9965.1810.13.11 Get It

Abstract Overweight [body mass index (BMI) 25.0-29.9 kg/m2] and obesity (BMI ≥30 kg/m2) are risk factors for several malignancies. The Iowa Women's Health Study was examined to determine whether increased BMI was associated with leukemia development. Over 40,000 Iowa women (ages 55-69 years) completed a self-administered lifestyle and health questionnaire in 1986 that included current height and weight. Two hundred women developed leukemia during the period 1986 to 2001 including 74 acute myelogenous leukemia (AML) and 88 chronic lymphocytic leukemia. The risk of AML was increased among women who reported being overweight or obese (relative risk, 1.9; 95% confidence interval, 1.0-3.4; relative risk, 2.4; 95% confidence interval, 1.3-4.5; Ptrend = 0.006) compared with women of normal weight. There was little evidence of a positive association for chronic lymphocytic leukemia (Ptrend = 0.6). Given the prevalence of overweight and obesity in the United States, the population attributable risk of AML due to obesity could approach 30%.